Trial of Pravastatin in Primary Isolated Hypercholesterolemia - RED-LIP

Description:

RED-LIP was an open, multicenter, prospective trial, evaluating safety and efficacy of pravastatin 10-40 mg once daily for three months in patients with primary isolated hypercholesterolemia.